Background Various approaches for endoscopic and minimally invasive thyroid operations have been reported, with some becoming popular to date. The aim of these procedures is to reduce and prevent visible scars in the neck. This led to the transoral endoscopic thyroidectomy vestibular approach (TOETVA) technique applicable in small thyroid specimen. To amend TOETVA and to broaden the indication for transoral thyroid surgery, our aim was to combine the TOETVA with the retroauricular endoscopic cephalic access thyroid surgery (EndoCATS) facelift approach. Methods After successful implementation of the TOETVA technique in 2017, we evaluated the transoral technique regarding feasibility and safety in well-selected patients in Germany and Austria. With the combination of TOETVA and EndoCATS, we were able to optimize the extraction process of the specimen by avoiding damage to the thyroid capsule and to broaden the indication of transoral surgery by operating on thyroid glands with higher volume. Patients' characteristics, surgical outcome and complications were determined. Results Seventy-one transoral procedures were performed in 70 patients. The TOETVA procedure was performed in 60 patients, and 10 female patients underwent TOVARA with transoral thyroid lobe mobilization and removal of the specimen via the retroauricular access. Overall, median operation time was 205 min (range 96-370 min) and permanent RLNP rate was 1% accordant to 99 nerves at risk (39 hemithyroidectomies, 29 total thyroidectomies, 2 parathyroid resections, and 1 thyroglossal cyst resection). No conversion to conventional open surgery was necessary. Long-term mental nerve injury occurred in two patients. No infection was identified. Conclusions Transoral thyroid and parathyroid surgery via the vestibular approach is both feasible and safe in Western Europe. The combination of the TOETVA with the retroauricular endoscopic cephalic access thyroid surgery (EndoCATS) facelift approach, called TOVARA, is a promising opportunity to allow for thyroid surgery without a visible scar in specimen with volume of more than 40 ml also.
Background
Like many other endoscopic and minimally invasive techniques in thyroid surgery, the aim of transoral thyroidectomy vestibular approach (TOETVA) is to reduce and prevent visible scars in the neck, less pain, a faster recovery and optimum cosmesis [1] [2] [3] [4] [5] [6] [7] [8] .
The TOETVA technique provides for a short distance between the incision site and the thyroid region and a convincing view to all important anatomic structures. This leads to an increase in patient`s safety and an excellent cosmetic outcome [9] .
Obviously, volume of the thyroid itself and size of the thyroid nodule(s) are the limiting factors in TOETVA and published data mostly refer to Asian and well-selected patients with small thyroid glands, small solitary thyroid nodules and a non-prominent chin. Transoral removal of thyroid glands of more than 30 ml and/or thyroid nodules larger than 25 mm is challenging and may cause additional tissue trauma. Current data suggest that 20 mm is the maximum diameter that can easily be extracted without breaking the specimen [10] .
To amend the TOETVA procedure and to broaden the indication for transoral thyroid surgery, our aim was to combine the TOETVA technique with the retroauricular endoscopic cephalic access thyroid surgery (EndoCATS) facelift approach that was first described by Schardey et al. [11] in 2008.
Based on our first preliminary experiences in two patients [12] , we now report on our implementation of the transoral thyroidectomy vestibular and retroauricular approach called TOVARA in a larger number of patients.
Methods
First, the TOETVA procedure was safely implemented in our surgical division in patients with small thyroid specimen and benign nodules ≤ 20 mm in diameter. To overcome limitations of the TOETVA procedure, patients with benign thyroid disease and a gland volume of more than 50 ml were identified to perform transoral surgery and removal of the specimen via the retroauricular access.
Preoperative thyroid investigations included ultrasonography, scintigraphy, laboratory values like thyroid-stimulating hormone (TSH), tetraiodo-I-thyronine (T4) and triiodo-Ithyronine (T3), autoantibodies, like thyrotropin receptor antibody (TRAK), anti-thyroperoxidase antibody (anti-TPO), calcitonin, parathyroid hormone (PTH) and calcium (CA) levels.
Vocal cord function was documented pre-as well as 2 days postoperatively by laryngoscopy. In case of recurrent laryngeal nerve palsy (RLNP), patients were re-evaluated 1 week and/or 4 weeks after surgery and, if necessary, logopaedics was initiated with reevaluation 3 and 6 months after surgery. RLNP rate was calculated by nerves at risk.
Paraesthesia in the chin area and lower lip due to mental nerve injury was documented postoperatively during hospital stay, 1 and 4 weeks after surgery. In case of persistent paraesthesia, patients were re-evaluated 3, 6 and 12 months after surgery. In addition, patients were introduced to grimacing and repeatedly activating their mimic muscles.
Serum calcium (Ca) as well as parathyroid hormone (PTH) levels were measured pre-and postoperatively at day 1. If hypocalcemia occurred, Ca and PTH were repeatedly measured at day 2 as well as 1, 4 and 8 weeks after surgery.
Inclusion and exclusion criteria for TOVARA are summarized in Table 1 .
Just as TOETVA, to perform TOVARA, patients are placed in a supine position with slight neck extension. All procedures were performed using intraoperative nerve monitoring (IONM). An endotracheal tube with an electrode for IONM (Dr. Langer Medical, Waldkirch, Germany) is placed transorally. In all cases, a long stimulating probe was used via one of the trocars. The mucosa of the oral cavity is cleansed with chlorhexidine solution. Afterwards, three linear incisions, 1.5-2 cm in the midline and 5 mm lateral right and left are made in the lower lip as close to the lip vermilion and as far away from the branches of the mental nerve as possible. Afterwards, a subplatysmal space is created by hydrodissection using an epinephrine-enriched saline solution injected with a Veress needle. The subplatysmal space is widened using a blunt dissector. Three trocars (originally one 10 mm and two 5 mm in diameter) are inserted through the midline and lateral incisions, followed by high flow CO 2 gas insufflation at a maximum pressure of 8 mmHg. Either a 5-mm or a 10-mm 30° full HD camera (Karl Storz GmbH, Tuttlingen, Germany) is used as well as conventional laparoscopic instruments. The subplatysmal working space reaches from the thyroid cartilage to the sternal notch and to the medial border of both sternocleidomastoid muscles. In addition to gas insufflation, two stitches are placed from outside to retract the strap muscles ventrally and laterally to optimize the working space ( Figs. 1, 2, 3 ). The strap muscles are divided in the midline and the thyroid lobe of one side will be mobilized. Next step is the division of the thyroid isthmus. After mobilization of the upper pole, the upper pole vessels are selectively sealed with a thermal device (Harmonic ACE, Ethicon, Cincinnati, OH, USA), followed by dissection of the lateral space and visualization and preservation of the upper parathyroid gland and the recurrent laryngeal nerve (Figs. 4 and 5). Intraoperative neuromonitoring (IONM) is performed routinely. The resected thyroid specimen is extracted through an additional retroauricular access and not via the midline access.
Following the original EndoCATS approach, skin incision is carried out on the scalp, behind the ear. Deep to the sternocleidomastoid muscle, but respecting the superficial cervical fascia, the preparation goes past the carotid triangle to reach the thyroid below the strap muscles of the neck (Figs. 6, 7, 8) .
Strap muscles are not adapted routinely at the end of the operation. Oral mucosa as well as retroauricular skin incision are closed using a 4/0 absorbable suture. 
Reasonable technical modifications
Meanwhile, both surgical techniques are well described and evaluated by many endocrine surgeons with promising results [9, 10, [13] [14] [15] [16] [17] [18] [19] [20] . After written informed consent was obtained by patients eligible for TOVARA, first the transoral access was performed, the trocars were placed, and the working space was created as mentioned.
Due to the combination of both techniques, it is possible to reduce tissue trauma by minimizing the midline incision to 0.5-1 cm instead of a 1.5-3 cm. A 5 mm trocar instead of a 10-12 mm trocar can be placed in the midline and, if available, 3 mm trocars and instrumentation can be used as well. In addition, the retroauricular access was modified and simplified. Instead of complex preparation in between the sternal and clavicular part of the sternocleidomastoid muscle using a special spatula, we were able to simplify the access using a 10-12 mm trocar which was subcutaneously placed by blunt dissection (Figs. 9 and 10).
Results
The TOETVA procedure was performed in 60 patients by three surgeons.
10 female patients underwent TOVARA with transoral thyroid lobe mobilization and removal of the specimen via the retroauricular access.
Clinical data of all patients who underwent transoral surgery are summarized in Table 2 . Data of patients who underwent TOVARA are summarized in Table 3 .
In all patients, calcitonin levels were within normal range. PTH and CA levels were elevated in patients who underwent transoral surgery for pHPT. TRAK were elevated in patients with Graves' disease, and anti-TPO antibodies were preoperatively elevated in ten patients.
Preoperative laryngoscopy showed inconspicuous vocal cord function in all patients.
Complete mobilization was performed transorally via the vestibular approach as described above. In TOVARA patients, the specimen was placed into an endobag which was inserted via the retroauricular access. The thyroid lobes were removed within the bag via the retroauricular approach without any damage to the thyroid capsule. Recurrent laryngeal nerve function was documented intraoperatively. In all patients with total thyroidectomy, one thyroid lobe was mobilized, resected and removed followed by documentation of an inconspicuous vagal nerve sign before the contralateral side was resected and extracted via the same right retroauricular access. Overall, median operation time was 205 min (range 96-370 min) and permanent RLNP rate was 1% accordant to 99 nerves at risk (39 hemithyroidectomies, 29 total thyroidectomies, 2 parathyroid resections, and 1 thyroglossal cyst resection).
The thyroglossal cyst was visualized and removed completely at the level of the hyoid bone using a thermal device (Ultracision ® ).
In the TOVARA group, median operation time was 220 min (range 170-370 min). In this group, IONM as well as postoperative laryngoscopy were inconspicuous in 9 out of 10 patients, accordant to 16 nerves at risk. In one of the ten patients who underwent TOVARA, loss of signal was obvious and postoperative laryngoscopy showed a palsy of the left vocal cord (4 hemithyroidectomies, 6 total thyroidectomies instead of 7 total thyroidectomies planned). Ten months after surgery, the voice handicap score was 4 out of 5 (no signs of dyspnea, normal voice without voice fatigue). In this patient with Graves` disease, therapy was completed by radioiodine 6 months after surgery. Postoperative Ca and PTH levels were within normal range without calcium supplementation in 64/70 patients (91%), while no permanent hypoparathyroidism occurred. Median hospital stay was 3 days.
The histopathologic result showed papillary thyroid microcarcinoma in three patients and stage T2 papillary thyroid carcinoma in one patient after right hemithyroidectomy. In this patient, reoperation and removal of the opposite thyroid lobe was performed via the transoral approach 2 days later. Corresponding to preoperative cervical ultrasonography, no suspicious lymphadenopathy was found. In addition, radioiodine therapy was performed 2 weeks after surgery.
Follow-up examinations were performed at day 7, day 30, 3 months, 6 months and 1 year postoperatively and showed good cosmetic and functional results. Except in one patient, no visible scars or physiognomic changes in the mouth, lip or chin area were evident. Unfortunately, one female patient who underwent TOETVA suffered from a small scar of 3 mm in the chin area due to a thermal injury of the skin. The lesion was treated conservatively. However, two patients suffered from persistent paraesthesia of the chin more than 1 year after surgery.
Discussion
Size of the thyroid specimen is the limiting factor in pure transoral thyroid surgery vestibular approach (TOETVA). Current data suggest that the optimum size of a thyroid nodule eligible for TOETVA is 2 cm and thyroid lobe volume should not exceed 30 ml [10] . Mainly, tissue tightness in the chin area precludes extraction of larger thyroid specimen via the midline access ( Fig. 11a-c) .
However, some patients with huge thyroid specimen not eligible for TOETVA would prefer thyroid surgery without visible scars in the neck if possible. Nevertheless, no compromises should be accepted regarding quality of the thyroid specimen especially the intactness of the thyroid capsule, regarding precise discrimination of benign and malignant follicular thyroid nodules.
Currently, only few extracervical techniques are available to reduce or avoid visible scars like the axillary bilateral breast approach (ABBA) or the trans-axillary access. However, since the first reports in 2000 [5, 6] , none of these techniques is widely used due to procedure-related disadvantages. With incisions performed in axilla and both areolar margins, ABBA is limited to females. However, a rather high number of women have concerns about the areolar incisions and extensive subcutaneous dissection in the décolleté area. In addition, there are only few highly specialized centres that perform ABBA or the technically demanding bilateral transaxillary operations in an adequate number of patients [21] .
EndoCATS is another well-evaluated cosmetically promising approach [11, [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] with skin incision in the retroauricular hairline. This access enables extraction of huge thyroid specimen and thyroid lobe volume to be extracted is nearly unlimited. However, disadvantages due to the access are a completely different perspective/view to the thyroid region and the limitation in thyroid volume that can be mobilized safely (maximum volume 45 ml). EndoCATS surgery is limited to the side of the access and surgery on the contralateral side requires an additional skin incision.
The combination of both techniques-EndoCATS and TOETVA-allows for total thyroidectomy (TOETVA) and mobilization of thyroid specimen larger than 45 ml. While TOETVA provides enough working space, extraction of the specimen without alteration of the thyroid capsule is warranted by the modified and simplified EndoCATS approach. Nevertheless, a high level of expertise in endocrine and laparoscopic minimally invasive surgery is required to safely implement this technique and despite thorough patient's selection a rather plain learning curve must be expected.
Since the first attempts in transoral surgery [33, 34] and the first promising results with TOETVA in a large series by Anuwong in 2014 [35] , the technique has been implemented and precisely evaluated in many specialized centres around the world [8-10, 13-20, 36, 37] . Our results regarding surgical outcome and complication rates are in line with current data and are comparable to traditional open thyroidectomy, minimally invasive thyroid surgery or other extracervical approaches [1, [4] [5] [6] [7] [8] [29] [30] [31] [32] .
Concerns regarding contamination or higher infection rates have already been refuted in the past [38] and by current data. However, in contrast to the extensively evaluated video-assisted open minimally invasive thyroid operation (MIVAT), further investigations and data are needed to finally assess newly emerging complications, like mental nerve injury with transient or permanent numbness in the lower lip or chin area, skin lesions with disastrous cosmetic and maybe functional results [39] . Permanent mental nerve injury is rare and can be avoided if mucosal incisions are made in the lower lip as close to the lip vermilion and as far away from the branches of the mental nerve as possible [9, 14, 37] . TOVARA allows for smaller incisions in the vestibular area especially in the midline and protection of the soft tissue, muscle and nerve fibres in the chin area because of the retroauricular extraction of the specimen. Shorter operation times may also lead to less exposure of soft tissue, muscles and nerve fibres.
Little information is available regarding the potential to perform transoral procedures in suspected or proven thyroid malignancy [18, 40, 41] . However, transoral thyroid surgery seems to provide adequate results in incidentally detected thyroid microcarcinoma and differentiated thyroid cancer and completion thyroidectomy is also feasible via the transoral approach.
Nevertheless, cost effectiveness, learning curves and new procedure-related complications and problems as well as long-term follow-up data must further be evaluated and reported [42] .
Conclusion
Transoral thyroid and parathyroid surgery via the vestibular approach is feasible and safe. The combination of TOETVA with the retroauricular endoscopic cephalic access thyroid surgery (EndoCATS) facelift approach, called TOVARA, is a promising opportunity to allow for thyroid surgery without a visible scar in specimen with volume of more than 40 ml also and this may help to protect soft tissue, muscle and nerve fibres in the vestibular and chin area during surgery and during the extraction process especially in a huge thyroid specimen.
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